期刊
NATURE
卷 451, 期 7176, 页码 335-U7出版社
NATURE PUBLISHING GROUP
DOI: 10.1038/nature06494
关键词
-
资金
- Howard Hughes Medical Institute Funding Source: Medline
- NCI NIH HHS [T32 CA009172] Funding Source: Medline
- NHLBI NIH HHS [R01 HL079583, R01 HL082945, K08 HL078818] Funding Source: Medline
Somatic chromosomal deletions in cancer are thought to indicate the location of tumour suppressor genes, by which a complete loss of gene function occurs through biallelic deletion, point mutation or epigenetic silencing, thus fulfilling Knudson's two- hit hypothesis(1). In many recurrent deletions, however, such biallelic inactivation has not been found. One prominent example is the 5q(-) syndrome, a subtype of myelodysplastic syndrome characterized by a defect in erythroid differentiation(2). Here we describe an RNA-mediated interference ( RNAi)- based approach to discovery of the 5q(-) disease gene. We found that partial loss of function of the ribosomal subunit protein RPS14 phenocopies the disease in normal haematopoietic progenitor cells, and also that forced expression of RPS14 rescues the disease phenotype in patient- derived bone marrow cells. In addition, we identified a block in the processing of pre- ribosomal RNA in RPS14- deficient cells that is functionally equivalent to the defect in Diamond- Blackfan anaemia, linking the molecular pathophysiology of the 5q(-) syndrome to a congenital syndrome causing bone marrow failure. These results indicate that the 5q(-) syndrome is caused by a defect in ribosomal protein function and suggest that RNAi screening is an effective strategy for identifying causal haploinsufficiency disease genes.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据